At the start of 2021, Sandoz performed a major reshuffle of its management in North America that saw regional head Carol Lynch move on to become the Novartis unit’s global chief business officer. At the same time, former Novartis head of mergers and acquisitions, Keren Haruvi, took over as president of Sandoz US and head of North America for the generics giant. (Also see "Haruvi Takes Charge Of Sandoz North America" - Generics Bulletin, 14 January, 2021.)
A couple of months on from her appointment, Haruvi has talked to Generics Bulletin about how Sandoz is seeking to...
